Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Salvage Stereotactic Radiotherapy (esSBRT) for Biochemical Failure After Radical Prostatectomy :a Phase II Study

NCT05667636 is registered in ClinicalTrials.gov with Regina Elena Cancer Institute as lead sponsor.

NCT NCT05667636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05667636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Salvage Stereotactic Radiotherapy (esSBRT) for Biochemical Failure After Radical Prostatectomy :a Phase II Study
Lead sponsor
Regina Elena Cancer Institute
Phase
Phase 2
Overall status
Unknown status
Start date
September 27, 2022
Completion date
September 27, 2024
Enrollment
103 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic neoplasm